Cyp2d6 Variants - Toxicology

Relevant Publications

Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System.

Issue Release: 2024

Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression.

Issue Release: 2024

Frequency of pharmacogenomic variants affecting efficacy and safety of anti-cancer drugs in a south Asian population from Sri Lanka.

Issue Release: 2024

Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedicated Control Group.

Issue Release: 2024

Predictive Model for Opioid Use Disorder in Chronic Pain: A Development and Validation Study.

Issue Release: 2024

Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol.

Issue Release: 2024

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.

Issue Release: 2024

Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.

Issue Release: 2024

Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea.

Issue Release: 2024

Phenotype-Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism.

Issue Release: 2024

Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.

Issue Release: 2024

An Effort to Identify Genetic Determinants in Siblings With Wilson Disease Manifesting Striking Clinical Heterogeneity: An Exome Profiling Study of Two Indian Families.

Issue Release: 2024

Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.

Issue Release: 2024

Leveraging in Vitro Models for Clinically Relevant Rare Variants in Pharmacogenomics.

Issue Release: 2024

A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential \'culprit\' for the tramadol \'abuse crisis\'.

Issue Release: 2024

Novel Independent Trans- and Cis-Genetic Variants Associated with CYP2D6 Expression and Activity in Human Livers.

Issue Release: 2024

Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis.

Issue Release: 2024

Fentanyl dosage for preterm infants suggested by a pharmacokinetic, -dynamic, and -genetic model.

Issue Release: 2024

CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania.

Issue Release: 2024

Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response.

Issue Release: 2024

How Does Animal Waste Impact Human Health?

Why is TPMT Important in Toxicology?

What Role Does Genotyping Play in Risk Assessment?

How is Orthostatic Hypotension Diagnosed in a Toxicological Setting?

What Are Pesticides?

What Are the Future Directions in Cellular Toxicity Research?

What is Exposure Science?

What Role Do Education and Awareness Play?

What are the Limitations of HepG2 Cells?

What Is the Role of Toxicology in Understanding Airborne Pollutants?

Cyp2d6 Variants - Toxicology

Relevant Publications

Partnered Content Networks

Relevant Topics